Assessment Of Health Technology Appraisals To Identify Key Drivers For Reimbursement Of Oncology Drugs With Only Phase 2 Clinical Data
Abstract
Authors
A Duran R Morlock X Lie R Dekkers R Gani A van Engen S Holmstrom
A Duran R Morlock X Lie R Dekkers R Gani A van Engen S Holmstrom
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now